Humacyte, Inc.

HUMANASDAQHealthcare● Active

$1.38

+$0.03(+2.22%)

Market Cap$231840000

P/E Ratio—

52W High$2.93

52W Low$0.547

Avg Volume7.4M

Open$1.40

Beta2.46

Insider Trades Ownership Employees

Humacyte, Inc. (HUMA) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · HUMA · as of Jun 8, 2026

Activity summary

Buy transactions

P-Purchase only

Sell transactions

12 Months

Buy/Sell ratio

1.00

Buy/Sell (by trades)

Overall sentiment

NEUTRAL

↑ Buy 50%Active transactions only · RSU vesting excluded50% Sell ↓

Humacyte, Inc. insiders have shown mixed buying and selling activity over the past 12 Months.

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 8, 2026

HUMA insider buying and selling by quarter

HUMA insider selling · HUMA insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling

4.5M2.2M0

2024 Q2

2024 Q3

2024 Q4

2025 Q1

2025 Q2

2025 Q3

2025 Q4

2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 8, 2026

Active insiders

Most active in past 12 months · HUMA ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

HUMA executive sell shares · HUMA board member insider trading · HUMA insider trading SEC filing

Showing 55 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Date	Insider	Type	Shares	Price	Value	After trans.	Filing
May 19, 2026	Sebelius Kathleen Director	Purchase	56,818	$0.88	$50K	148,025	Form 4
May 18, 2026	Constantino Michael T. Director	Purchase	11,000	$0.89	$10K	43,950	Form 4
May 18, 2026	Sander Dale A. CFO and Chief Corp. Dev. Off	Sale	45,887	$0.90	$41K	267,213	Form 4
May 18, 2026	Parikh Shamik J Chief Medical Officer	Sale	45,887	$0.90	$41K	272,713	Form 4
Nov 16, 2025	Sander Dale A. CFO and Chief Corp. Deve. Off.	Award	311,100	—	—	313,100	Form 4
Nov 16, 2025	Parikh Shamik J Chief Medical Officer	Award	311,100	—	—	318,600	Form 4
Aug 18, 2025	Dougan Brady W Director	Sale	549,360	$1.83	$1.01M⚡	1,691,685	Form 4
Aug 19, 2025	Dougan Brady W Director	Sale	1,100,000	$1.63	$1.79M⚡	591,685	Form 4
Aug 20, 2025	Dougan Brady W Director	Sale	591,685	$1.58	$935K	0	Form 4
Aug 18, 2025	Niklason Laura E President, CEO and Director	Sale	549,360	$1.83	$1.01M⚡	1,691,685	Form 4
Aug 19, 2025	Niklason Laura E President, CEO and Director	Sale	1,100,000	$1.63	$1.79M⚡	591,685	Form 4
Aug 20, 2025	Niklason Laura E President, CEO and Director	Sale	591,685	$1.58	$935K	0	Form 4
Apr 14, 2025	Scheessele William John Chief Commercial Officer	Purchase	6,493	$1.54	$10K	22,018	Form 4
Apr 10, 2025	Sander Dale A. CFO and Chief Corp. Deve. Off.	Purchase	20,000	$1.53	$31K	40,600	Form 4
Apr 10, 2025	Parikh Shamik J Chief Medical Officer	Purchase	7,500	$1.55	$12K	7,500	Form 4
Apr 8, 2025	Sebelius Kathleen Director	Purchase	50,000	$1.32	$66K	91,207	Form 4
Apr 8, 2025	Green Charles Bruce Director	Purchase	6,000	$1.29	$8K	8,400	Form 4
Apr 7, 2025	Constantino Michael T. Director	Purchase	16,000	$1.26	$20K	32,950	Form 4
Dec 4, 2024	Constantino Michael T. Director	Purchase	4,600	$4.39	$20K	16,950	Form 4
Nov 19, 2024	Niklason Laura E President, CEO and Director	Purchase	1,797	$4.44	$8K	243,851	Form 4
Nov 19, 2024	Dougan Brady W Director	Purchase	1,797	$4.44	$8K	243,851	Form 4
Nov 18, 2024	Niklason Laura E President, CEO and Director	Sale	811,172	$4.44	$3.60M⚡	2,419,712	Form 4
Nov 19, 2024	Niklason Laura E President, CEO and Director	Sale	427,459	$4.34	$1.86M⚡	1,992,253	Form 4
Nov 20, 2024	Niklason Laura E President, CEO and Director	Sale	261,369	$4.40	$1.15M⚡	1,730,884	Form 4
Nov 18, 2024	Dougan Brady W Director	Sale	811,172	$4.44	$3.60M⚡	2,419,712	Form 4

Sebelius Kathleen

Director

Purchase

Date

May 19

56,818

Price

$0.88

Value

$50K

View Form 4 on SEC.gov

Constantino Michael T.

Director

Purchase

Date

May 18

11,000

Price

$0.89

Value

$10K

View Form 4 on SEC.gov

Sander Dale A.

CFO and Chief Corp. Dev. Off

Sale

Date

May 18

45,887

Price

$0.90

Value

$41K

View Form 4 on SEC.gov

Parikh Shamik J

Chief Medical Officer

Sale

Date

May 18

45,887

Price

$0.90

Value

$41K

View Form 4 on SEC.gov

Sander Dale A.

CFO and Chief Corp. Deve. Off.

Award

Date

Nov 16

311,100

Price

—

Value

—

View Form 4 on SEC.gov

Parikh Shamik J

Chief Medical Officer

Award

Date

Nov 16

311,100

Price

—

Value

—

View Form 4 on SEC.gov

Dougan Brady W

Director

Sale

Date

Aug 18

549,360

Price

$1.83

Value

$1.01M ⚡

View Form 4 on SEC.gov

Dougan Brady W

Director

Sale

Date

Aug 19

1,100,000

Price

$1.63

Value

$1.79M ⚡

View Form 4 on SEC.gov

Dougan Brady W

Director

Sale

Date

Aug 20

591,685

Price

$1.58

Value

$935K

View Form 4 on SEC.gov

Niklason Laura E

President, CEO and Director

Sale

Date

Aug 18

549,360

Price

$1.83

Value

$1.01M ⚡

View Form 4 on SEC.gov

Niklason Laura E

President, CEO and Director

Sale

Date

Aug 19

1,100,000

Price

$1.63

Value

$1.79M ⚡

View Form 4 on SEC.gov

Niklason Laura E

President, CEO and Director

Sale

Date

Aug 20

591,685

Price

$1.58

Value

$935K

View Form 4 on SEC.gov

Scheessele William John

Chief Commercial Officer

Purchase

Date

Apr 14

6,493

Price

$1.54

Value

$10K

View Form 4 on SEC.gov

Sander Dale A.

CFO and Chief Corp. Deve. Off.

Purchase

Date

Apr 10

20,000

Price

$1.53

Value

$31K

View Form 4 on SEC.gov

Parikh Shamik J

Chief Medical Officer

Purchase

Date

Apr 10

7,500

Price

$1.55

Value

$12K

View Form 4 on SEC.gov

Sebelius Kathleen

Director

Purchase

Date

Apr 8

50,000

Price

$1.32

Value

$66K

View Form 4 on SEC.gov

Green Charles Bruce

Director

Purchase

Date

Apr 8

6,000

Price

$1.29

Value

$8K

View Form 4 on SEC.gov

Constantino Michael T.

Director

Purchase

Date

Apr 7

16,000

Price

$1.26

Value

$20K

View Form 4 on SEC.gov

Constantino Michael T.

Director

Purchase

Date

Dec 4

4,600

Price

$4.39

Value

$20K

View Form 4 on SEC.gov

Niklason Laura E

President, CEO and Director

Purchase

Date

Nov 19

1,797

Price

$4.44

Value

$8K

View Form 4 on SEC.gov

Dougan Brady W

Director

Purchase

Date

Nov 19

1,797

Price

$4.44

Value

$8K

View Form 4 on SEC.gov

Niklason Laura E

President, CEO and Director

Sale

Date

Nov 18

811,172

Price

$4.44

Value

$3.60M ⚡

View Form 4 on SEC.gov

Niklason Laura E

President, CEO and Director

Sale

Date

Nov 19

427,459

Price

$4.34

Value

$1.86M ⚡

View Form 4 on SEC.gov

Niklason Laura E

President, CEO and Director

Sale

Date

Nov 20

261,369

Price

$4.40

Value

$1.15M ⚡

View Form 4 on SEC.gov

Dougan Brady W

Director

Sale

Date

Nov 18

811,172

Price

$4.44

Value

$3.60M ⚡

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 3

▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About HUMA insider trading

HUMA insider trades

Humacyte, Inc. (HUMA) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Dougan Brady W (Director), Niklason Laura E (President, CEO and Director), Sander Dale A. (CFO and Chief Corp. Dev. Off). Over the past 12 months, 5 insiders have filed transactions with the SEC. HUMA insiders have been mixed buying and selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Humacyte, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic

acquisitionOrDisposition field:

A = Acquisition (buy) · D = Disposition (sell)

RSU vesting (M-Exempt) excluded from sentiment

Form 4SEC filing required within 2 business days of any insider transaction

10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot

Open MktDirect purchase or sale on the open market (excludes awards, options)

Ownership SEC filings Financial statements Price history Forecast & ratings Earnings

Frequently asked questions

HUMA insider trading · 5 questions

The insiders of Humacyte, Inc. (HUMA) include executives and directors such as Dougan Brady W (Director), Niklason Laura E (President, CEO and Director), Sander Dale A. (CFO and Chief Corp. Dev. Off), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

HUMA board member insider tradingwho are HUMA insidersHUMA insider rosterHumacyte, Inc. executives insider activity

▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026